
SPDR S&P US Health Care Select Sector UCITS ETF
SPDR S&P US Health Care Select Sector UCITS ETF (GB:SXLV) Price & Chart
GB:SXLV ETF Chart & Stats
- Day’s Range
- $56.87 - $57.79
- 52-Week Range
- $44.03 - $59.97
- Previous Close
- $58.00
- Volume
- 6,799
- Average Volume (3M)
- 50.98K
- AUM
- 598.49M
- NAV
- 51.53
- Expense Ratio
- 0.15%
- Holdings Count
- 62
- Beta
- 0.71
- Inception Date
- Jul 07, 2015
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 11,050,000
- Standard Deviation
- N/A
ETF Overview
SPDR S&P US Health Care Select Sector UCITS ETF
The SPDR S&P US Health Care Select Sector UCITS ETF (Ticker: SSEHF) offers investors a strategic gateway to the dynamic and ever-evolving U.S. healthcare sector. This ETF is meticulously designed to capture the performance of the S&P Health Care Select Sector Index, making it a quintessential choice for those seeking exposure to the broad spectrum of healthcare-related industries, from pharmaceuticals and biotechnology to healthcare equipment and services. In the vast landscape of sector-focused investment options, SSEHF stands out by honing in on a niche that is both broad-based and essential: the U.S. healthcare industry. This sector is not only a critical component of the economy but also a hotbed of innovation and growth, driven by technological advancements, an aging population, and increasing global demand for healthcare solutions. The SPDR S&P US Health Care Select Sector UCITS ETF is crafted for investors who understand the transformative potential of healthcare and are eager to align their portfolios with a sector that is pivotal to both economic resilience and societal well-being. With its targeted focus, the ETF provides a diversified exposure to a wide array of leading healthcare companies, offering a balanced blend of stability and growth prospects. In summary, SSEHF is more than just an investment vehicle; it is a strategic tool for those looking to capitalize on the robust and resilient healthcare sector. Whether you're a seasoned investor or new to sector-focused strategies, this ETF presents an engaging opportunity to participate in the ongoing evolution of healthcare, a sector that remains at the forefront of innovation and impact.
- Asset Class
- Equity
- Region
- North America
- Issuer
- SPDR
- Index Tracked
- S&P Health Care Select Sector Daily Capped 35/20 Index
- Ticker Symbol
- GB:SXLV
GB:SXLV ETF News


Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer’s VESPER-SUI study is officially titled “A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer’s CORRELATE-UK study, officially titled CORRELATE-UK: COnsistency of Response With RimegEpant Oral Lyophilisate in Acute Treatment of









